168 related articles for article (PubMed ID: 24062991)
21. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
[TBL] [Abstract][Full Text] [Related]
22. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
Reineke EL; Kao HY
Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
[TBL] [Abstract][Full Text] [Related]
23. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
[TBL] [Abstract][Full Text] [Related]
24. The promyelocytic leukemia nuclear body: sites of activity?
Eskiw CH; Bazett-Jones DP
Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
[TBL] [Abstract][Full Text] [Related]
25. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
26. PML tumour suppression and beyond: therapeutic implications.
Gamell C; Jan Paul P; Haupt Y; Haupt S
FEBS Lett; 2014 Aug; 588(16):2653-62. PubMed ID: 24548562
[TBL] [Abstract][Full Text] [Related]
27. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
28. Restoration of promyelocytic leukemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness.
Yu JH; Nakajima A; Nakajima H; Diller LR; Bloch KD; Bloch DB
Cancer Res; 2004 Feb; 64(3):928-33. PubMed ID: 14871822
[TBL] [Abstract][Full Text] [Related]
29. Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.
Wang WH; Kuo CW; Chang LK; Hung CC; Chang TH; Liu ST
J Virol; 2015 Sep; 89(17):8922-31. PubMed ID: 26085145
[TBL] [Abstract][Full Text] [Related]
30. Emerging Cellular Functions of Cytoplasmic PML.
Jin G; Wang YJ; Lin HK
Front Oncol; 2013; 3():147. PubMed ID: 23761861
[TBL] [Abstract][Full Text] [Related]
31. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
32. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic PML: from molecular regulation to biological functions.
Jin G; Gao Y; Lin HK
J Cell Biochem; 2014 May; 115(5):812-8. PubMed ID: 24288198
[TBL] [Abstract][Full Text] [Related]
34. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
35. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
36. Stemming out of a new PML era?
Salomoni P
Cell Death Differ; 2009 Aug; 16(8):1083-92. PubMed ID: 19521423
[TBL] [Abstract][Full Text] [Related]
37. Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity.
Korb E; Wilkinson CL; Delgado RN; Lovero KL; Finkbeiner S
Nat Neurosci; 2013 Jul; 16(7):874-83. PubMed ID: 23749147
[TBL] [Abstract][Full Text] [Related]
38. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
[TBL] [Abstract][Full Text] [Related]
39. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
[TBL] [Abstract][Full Text] [Related]
40. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
